Compare ARQT & USAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARQT | USAC |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.1B |
| IPO Year | 2020 | 2011 |
| Metric | ARQT | USAC |
|---|---|---|
| Price | $28.05 | $26.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $34.00 | $26.67 |
| AVG Volume (30 Days) | ★ 1.7M | 273.7K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 7.72% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $376,072,000.00 | ★ $698,365,000.00 |
| Revenue This Year | $34.85 | $33.35 |
| Revenue Next Year | $29.39 | $6.09 |
| P/E Ratio | ★ N/A | $31.25 |
| Revenue Growth | ★ 91.34 | 19.51 |
| 52 Week Low | $13.70 | $21.85 |
| 52 Week High | $31.77 | $30.55 |
| Indicator | ARQT | USAC |
|---|---|---|
| Relative Strength Index (RSI) | 61.54 | 50.61 |
| Support Level | $27.63 | $25.98 |
| Resistance Level | $29.91 | $28.79 |
| Average True Range (ATR) | 1.20 | 0.80 |
| MACD | -0.06 | 0.11 |
| Stochastic Oscillator | 62.20 | 65.85 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.